Radiolucent Spacer Imaging Marker for Radiation Dose Accuracy

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing imaging markers for radiation treatment planning and simulation cause 'dose perturbation' or radiation 'hot spots' due to their radiopaque portions being absorbed by treatment planning software, leading to incorrect radiation dose calculations, as they are not distinguishable from the patient's tissue in x-ray images.

Innovation Solution

An imaging marker with a radiolucent spacer between the adhesive and the radiopaque marker, which spaces the marker at least 1 millimeter away from the skin, preventing software from including it as part of the patient's body and ensuring accurate radiation dose calculations.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If the radiopaque marker is placed directly on the skin surface, then the marker is clearly visible in imaging scans, but the treatment planning software incorrectly includes the marker as part of the patient's body, causing dose perturbation

Engineering Contradiction:
Improvemarker visibility in imagingVSAvoidradiation dose calculation accuracy
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

A radiolucent spacer material is introduced between the radiopaque marker and the patient's skin. This intermediary layer allows the marker to remain visible in imaging scans while preventing the treatment planning software from incorrectly including it as part of the patient's body, thereby eliminating dose perturbation and ensuring accurate radiation dose calculations.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Difficulty of detecting and measuring

If the marker is made radiopaque for clear imaging, then the marker is easily detected in scans, but it creates radiation hot spots and requires manual contouring

Engineering Contradiction:
Improvemarker detection in scansVSAvoidmanual contouring requirement
Core Design Contradiction:
Difficulty of detecting and measuringVSDevice complexity

Solution Approach 1:

The marker system is segmented into two distinct components: a radiopaque marker portion for detection in scans and a radiolucent spacer portion that prevents interference with dose calculations. This segmentation allows the marker to be automatically detected by imaging software without requiring manual contouring to remove it from the treatment plan.

Inventive Principle:
Principle #1Segmentation

3Manufacturing precision

If the marker is placed close to the skin, then it accurately marks the treatment area, but it causes dose perturbation that requires additional manual intervention

Engineering Contradiction:
Improvemarker positioning accuracyVSAvoidmanual contouring time
Core Design Contradiction:
Manufacturing precisionVSLoss of time

Solution Approach 1:

The radiolucent spacer acts as a mediator that maintains the marker's close proximity to the skin for accurate treatment area marking while preventing the marker from causing dose perturbation. This eliminates the need for manual contouring and associated time losses.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Prevents the need for manual contouring of the marker, reducing the time and expense associated with radiation treatment planning and simulation by avoiding 'dose perturbation' and ensuring accurate radiation delivery.

Implementation Method 1

the marker is formed by at least one radiopaque portion that is substantially radiopaque at a level of radiation used by the imager

Methodology Applied
Scientific EffectX-ray absorption: Absorption (EM radiation)

Implementation Method 2

the spacer is substantially radiolucent at the level of radiation used by the imager in connection with the radiation treatment planning and/or simulation

Methodology Applied
Scientific EffectX-ray transmission: X-Ray

Data Source

PatentUS20220160455A1Imaging marker and method
Publication Date: 2022.05.26 BEEKLEY CORP
  • US20220160455A1 patent drawing
  • US20220160455A1 patent drawing

AI summary

An imaging marker is radiopaque at the level of radiation used during a radiation treatment planning and/or simulation. An adhesive layer is configured to releasably attach the imaging marker to a surface of a patient's skin. A radiolucent spacer is located between the adhesive layer and the radiopaque marker, and is radiolucent at the level of radiation used during the radiation treatment planning and/or simulation. The radiolucent spacer defines a thickness between the adhesive and substantially the entirety of the underside of the radiopaque marker of at least about 1 millimeter, and therefore spaces substantially the entirety of the underside of the radiopaque marker at least about 1 millimeter away from the skin.